AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 101 min read$MANH

Hollembaek Linda T. sold $300K of MANH

Hollembaek Linda T. sold 1,579 shares of MANHATTAN ASSOCIATES INC (MANH) at $189.88 ($0.30M total) on 2026-08-06.

Original reporting
SEC EDGAR · Hollembaek Linda T.
Published Aug 10, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MANH
Neutral
high confidence
Mentioned
$MANH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MANHNeutralLow
01

Why it matters

The newest disclosed fact is the director’s open-market sale of 1,579 shares at $189.8801, totaling about $299,820.68, with holdings after sale of 12,268 shares.

02

Market read

Traders may note insider selling, but there is no accompanying operational, financial, or regulatory catalyst in the text.

03

What to watch

The article provides no context on total compensation, tax planning, or whether other insiders sold/bought around the same time.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-10, transaction dated 2026-08-06

Background

This is an SEC Form 4 insider transaction disclosure for Manhattan Associates (MANH).

Company-level read

Ticker impact

$MANHNeutralHigh confidence
Context

MANH is the issuer of a Form 4 showing director Hollembaek Linda T sold 1,579 shares at $189.8801 on 2026-08-06.

Expected impact

Likely minimal near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company-specific news, guidance, or event.

Market effects

Sector

None indicated; this is a single-company insider sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The absence of a 10b5-1 plan could be interpreted as discretionary selling, but insider sales are often liquidity-driven and not reliably predictive.

Key entities

  • issuer
    MANHATTAN ASSOCIATES INC

    Company whose director insider sale is disclosed on Form 4.

  • insider
    Hollembaek Linda T.

    Director who sold 1,579 shares on 2026-08-06.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MANH insider trading history →

Related articles

OCT 27
$HOODMed

Stocks making the biggest moves after hours: Visa, Robinhood, NXP, Seagate and more

After-hours movers: Robinhood (HOOD) fell 5% with lower 2026 expense forecast. Seagate (STX) sank 6% despite earnings beat. NXP (NXPI) dropped 9% on in-line revenue outlook. F5 (FFIV) slid 1% with margins slightly below estimates. Visa (V) dipped 2% on lower margin. CoStar (CSGP) fell 11% despite earnings beat and acquisition. Manhattan Associates (MAN) rose 10% on raised guidance. PPG (PPG) jumped 7% on earnings beat and raised outlook. Enphase (ENPH) dropped 14% on lower revenue projections.

cnbc.com3 min
OCT 27
$MANHHighAI 8/10

MANHATTAN ASSOCIATES INC (MANH): Completion of Acquisition or Disposition of Assets

MANHATTAN ASSOCIATES INC (MANH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Contact: Michael Bauer Devika Goel VP, Investor Relations Director, Corporate Communications & PR Manhattan Associates, Inc. Manhattan Associates, Inc. 678-597-7538 678-597-6754 mbauer@manh.com dgoel@manh.com Manhattan Associates Reports Third Quarter Results Cloud R

SEC EDGAR 8-K3 min
OCT 12
$MANHMed

Why Manhattan Associates (MANH) Stock Is Trading Up Today

Manhattan Associates (MANH) stock rose 4% premarket after Morgan Stanley upgraded it to Overweight with a $250 price target, citing accelerating cloud bookings and AI-driven growth. The company's shares have gained 30.6% year-to-date and are near their 52-week high. According to Morgan Stanley, Manhattan is transitioning into an AI beneficiary with strong customer feedback on its software tools.

financialcontent.com4 min
OCT 12
$MANHHigh

Why is Manhattan Associates stock surging today?

Manhattan Associates (MANH) stock rose 4.2% pre-market after Morgan Stanley upgraded it to Overweight, raising its price target to $250 from $180. The firm cited accelerating cloud bookings, strong AI traction, and attractive valuation. The company reported Q2 2026 earnings of $1.39 per share on $297.8M revenue and raised full-year cloud revenue guidance.

investing.com1 min